Cosmetic and Clinical Applications of Botox and Dermal Fillers

There has been a recent explosion of public interest in less invasive facial rejuvenation products and treatments. At the forefront of this are the U.S. FDA Approvals of Botox and Xeomin injections.
 
In addition to the broad array of cosmetic applications for botulinum toxin, a new range of functional treatments is similarly beginning to emerge. These treatments include creating a “chemical” tarsorrhaphy to promote corneal healing, reducing thyroid-associated eyelid retraction, and—most compelling—reducing the frequency and severity of muscle tension and migraine headaches. These new applications significantly expand the scope of botulinum toxin treatments for medical disorders that have traditionally included the treatment of strabismus as well as a number of disorders of spasticity.